Health Care Law

HB Ad Slot
HB Mobile Ad Slot

Healthcare law is constantly changing, especially in today’s data driven online world.  Healthcare providers have unprecedented concerns related to privacy and cybersecurity as different technologies and threats intersect in ways never seen before.  With the growth of cloud computing and electronic health records, more regulations and greater scrutiny has been given to the industry, as hospitals, medical providers and healthcare agencies are liable in new and different ways.

The National Law Review covers all legal aspects of the healthcare industry, with expert legal analysis on HIPAA regulations, non-profit organization status, to home health and nursing care abuse.   Additionally, the National Law Review covered all aspects of the Affordable Care Act, or Obamacare, and its implementation, as well as the various attempts to repeal the ACA and new legislation in the healthcare arena, including the American Health Care Act of 2017.

Visitors can read about the US Department of Health and Human Services (HHS), the Office for Civil Rights (OCR), and regulations being promulgated by the Food and Drug Administration (FDA). The Center for Medicare & Medicaid Services (CMS) is also frequently discussed as it relates to drug pricing plans and premiums, new insurance policy requirements and other industry norms.

A major issue in healthcare is the prominence of Ransomware attacks and other cybersecurity concerns, as they relate to patient protected information and HIPAA compliance.  Healthcare systems wanting to maintain compliance with HIPAA regulations and protect patient privacy can find legal analysis and information on how to do so.

Additionally, the rise of Telehealth initiatives in a variety of areas is another area covered by the National Law Review.  With these new technologies, there is a lot of opportunity for innovation, however, careful understanding of telehealth legislation, reimbursement policies and regulations is essential to maintain a standard of care and avoid litigation.

Hospice care, the opioid epidemic, Medicare reimbursement, and issues with antitrust when healthcare systems merge are among the news stories covered by the National Law Review.  Visitors will consistently find updated stories on regulating medical devices, new life sciences technologies, and legislative developments in the healthcare arena. Because the industry is ever-changing, the National Law Review always has new content related to healthcare law.

National Law Review Healthcare Law XFor hourly updates in the latest news about Healthcare & Health Management law, regulations, and legislation, be sure to follow our Health Law X (formerly Twitter) feed, and sign up here for our daily complimentary e-news bulletins.

Recent Health Care, Medicare, ACA, HIPAA & OIG Law News

Title
Custom text Organization Sort descending
Jun
27
2019
Final Regulations Permit Employers to Reimburse an Employee’s Costs for the Purchase of an Individual Health Insurance Policy
May
4
2020
HHS Announces Disbursement of Additional $20 Billion from Provider Relief Fund COVID-19 Sills Cummis & Gross P.C.
Oct
10
2011
Six Important Strategies To Reduce The Royalty Burden For A Pharmaceutical Product Sills Cummis & Gross P.C.
Feb
6
2012
Product Liability Claims Against Generics After Pliva v. Mensing: Do Any Claims Survive? Sills Cummis & Gross P.C.
May
17
2009
Stimulus Law Amends COBRA Sills Cummis & Gross P.C.
May
20
2009
New Jersey Product Liability Jurisprudence: Highlights of 2008 and Anticipated Developments in 2009 Sills Cummis & Gross P.C.
Aug
8
2011
Pliva, Inc. v. Mensing–United States Supreme Court Holds That Failure To Warn Claims Against Generic Pharmaceutical Manufacturers Are Pre-Empted By Federal Law Sills Cummis & Gross P.C.
May
29
2009
DOL Revises Family Leave Regulations Sills Cummis & Gross P.C.
May
17
2012
Buyers And Sellers Beware – Federal And State Antitrust Authorities Heighten Scrutiny Of Healthcare Provider M&A Sills Cummis & Gross P.C.
Jun
3
2012
Five Traps for the Unwary Licensee Sills Cummis & Gross P.C.
Jul
25
2019
Weeding through the NJ Medical Marijuana Law Amendments: What You Need to Know Sills Cummis & Gross P.C.
May
29
2009
New Jersey Paid Family Leave Law Takes Effect Sills Cummis & Gross P.C.
May
1
2013
Alabama Supreme Court: Brand-Name Pharmaceutical Manufacturer Can Be Sued for Injury Caused by Generic Product Sills Cummis & Gross P.C.
Sep
3
2021
Health Care Settings Subject to New COVID-19 Requirements Issued by New Jersey and OSHA Sills Cummis & Gross P.C.
May
29
2009
Third Circuit: Title VII Bars Discrimination Against Employees Who Had An Abortion Sills Cummis & Gross P.C.
Jan
17
2018
Registered Surgical Practice Bill Signed into Law Sills Cummis & Gross P.C.
Oct
4
2013
Affordable Care Act (ACA) Exchanges “Go Live” on October 1, 2013: Immediate Action Required by Employers Sills Cummis & Gross P.C.
Jun
7
2014
Dietary Supplement Health and Education Act (DSHEA) – 20 Years Later – The Good, The Bad And The Ugly Sills Cummis & Gross P.C.
May
29
2009
New Jersey To Enact Paid Family Leave Law Sills Cummis & Gross P.C.
Dec
6
2009
Effective Use of A Regulatory Expert In Product Liability Litigation Sills Cummis & Gross P.C.
Jul
10
2011
FTC And DOJ Issue Proposed Statement Of Antitrust Policy Regarding Accountable Care Organizations Seeking To Participate In The Medicare Shared Savings Program Sills Cummis & Gross P.C.
May
19
2012
Kendall v. Hoffman-LaRoche, Inc. – The Interplay between the New Jersey Product Liability Act's Presumption of Adequacy for FDA-Approved Warnings and the Discovery Rule in Evaluating a Statue of Limitations Defense Sills Cummis & Gross P.C.
Mar
24
2020
Latest Update: New Jersey & New York Governors Issue New, Expansive COVID-19 Executive Orders Sills Cummis & Gross P.C.
May
29
2009
New York Court: Contract Determines Whether Employment Becomes At Will After Expiration Sills Cummis & Gross P.C.
Nov
9
2010
Antitrust Considerations In Forming ACOs And Bundled Payment Arrangements Under The Healthcare Reform Act Sills Cummis & Gross P.C.
May
29
2009
New York Resolves Uncertainty Over Whistleblower Waiver And Scope Issues Sills Cummis & Gross P.C.
May
2
2013
POM Wonderful – Where Are We Now? Re: Federal Trade Commission (FTC) and Deceptive Advertising Sills Cummis & Gross P.C.
Jan
17
2017
Office of Inspector General Enacts New Safe Harbors and Policy Statement under the Anti-Kickback Statute Sills Cummis & Gross P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins